Physician
Pathology
Dr. Wozhan Tang, MD
|
|
Give Review
Wozhan Tang is an expert in the field of Pathology. He researched medicine at Guangzhou Medical College. Wozhan Tang, MD is a published MD as well. He has 67 publications published. The latest was: Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.
Publications
- Management of Cardio-Renal Syndrome and Diuretic Resistance.
- Transient Hyponatremia During Hospitalization for Acute Heart Failure.
- Novel Biomarkers of Heart Failure: Do They Have Incremental Clinical Utility?
- Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
- Usefulness of Relative Hypochromia in Risk Stratification for Nonanemic Patients With Chronic Heart Failure.
- Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.
- Contribution of environmental toxins in the pathogenesis of idiopathic cardiomyopathies.
- Comparison of left ventricular torsion and strain with biventricular pacing in patients with underlying right bundle branch block versus those with left bundle branch ...
- Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
- Chitin Is Endogenously Produced in Vertebrates.
- Renal failure requiring dialysis complicating slow continuous ultrafiltration in Acute heart failure: importance of systolic perfusion pressure.
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
- Can we save the kidneys by protecting the heart?
- Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in Chronic kidney disease.
- Usefulness of Neutrophil-to-Lymphocyte Ratio in Risk Stratification of Patients With Advanced Heart Failure.
- Long-term outcomes in patients with ambulatory new york heart association class III and IV heart failure undergoing cardiac resynchronization therapy.
- Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure.
- A combined-biomarker approach to clinical phenotyping renal dysfunction in heart failure.
- RNA-Seq identifies novel myocardial gene expression signatures of heart failure.
- γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO.
- Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
- Comparative Assessment of Short-term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial.
- Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction and Adverse Clinical Outcomes in Chronic Systolic Heart Failure.
- Reverse ventricular remodeling and long-term survival in patients undergoing cardiac resynchronization with surgically versus percutaneously placed left ventricular pa...
- Hypotension During Hospitalization for Acute Heart Failure Is Independently Associated With 30-Day Mortality: Findings From ASCEND-HF.
- Prognostic Comparison of Different Sensitivity Cardiac Troponin Assays in Stable Heart Failure.
- Natriuretic Peptide Testing in High-Risk Pregnancy: A Preventive Opportunity?
- Prognostic Significance of Left Atrial Appendage "Sludge" in Patients with Atrial Fibrillation: A New Transesophageal Echocardiographic Thromboembolic Risk Factor.
- Nesiritide, Renal Function, and Associated Outcomes During Hospitalization for Acute Decompensated Heart Failure: Results From the Acute Study of Clinical Effectivenes...
- Prognostic Value of Estimating Functional Capacity Using the Duke Activity Status Index in Stable Patients with Chronic Heart Failure.
- Autoantibodies and Cardiovascular Dysfunction: Cause or Consequence?
- Precision of Echocardiographic Estimates of Right Atrial Pressure in Patients with Acute Decompensated Heart Failure.
- Contemporary insights and novel treatment approaches to central sleep apnea syndrome in heart failure.
- Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with Chronic systolic heart failure.
- Incidence, predictors, and impact on survival of left ventricular systolic dysfunction and recovery in advanced cancer patients.
- S100A1 in Human Heart Failure: Lack of Recovery Following LVAD Support.
- Utilization pattern of mineralocorticoid receptor antagonists in contemporary patients hospitalized with Acute decompensated heart failure: a single-center experience.
- Insufficient Natriuretic Response to Continuous Intravenous Furosemide Is Associated with Poor Long-Term Outcomes in Acute Decompensated Heart Failure.
- Comparative Genome-Wide Association Studies in Mice and Humans for Trimethylamine N-Oxide, a Proatherogenic Metabolite of Choline and L-Carnitine.
- Right Ventricular Global Longitudinal Strain Provides Prognostic Value Incremental to Left Ventricular Ejection Fraction in Patients with Heart Failure.
- A clinical prediction rule to identify patients at heightened risk for early demise following cardiac resynchronization therapy.
- Durability of Survival Effect of Cardiac Resynchronization Therapy by Level of Left Ventricular Functional Improvement: Fate of "Non-Responders"
- Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study).
- Double-chambered right ventricle and bicuspid pulmonic valve: a thrilling discovery.
- An abundant dysfunctional apolipoprotein A1 in human atheroma.
- Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
- Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases.
- Survival of patients with biventricular devices after device infection, extraction, and reimplantation.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Treatment strategies for the prevention of heart failure.
- Angiotensin-Converting Enzyme 2 as a Therapeutic Target for Heart Failure.
- Biomarkers of Acute kidney injury in chronic heart failure: what do the signals mean?
- Increased Need for Right Ventricular Support in Patients with Chemotherapy-Induced Cardiomyopathy Undergoing Mechanical Circulatory Support: Outcomes from the INTERMAC...
- Impact of left ventricular diastolic function on left atrial mechanics in systolic heart failure.
- Efficacy of the CHADS2 Scoring System to Assess Left Atrial Thrombogenic Milieu Risk Before Cardioversion of Non-Valvular Atrial Fibrillation.
- Increasing serum soluble Angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in Acute decompensated heart fail...
- Prognostic Implications of Relative Hypochromia in Ambulatory Patients With Chronic Systolic Heart Failure.
- Genome-wide and Gene-Centric Analyses of Circulating Myeloperoxidase Levels in the CHARGE and CARe Consortia.
- Protein carbamylation in Chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes.
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis.
- Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2).
- Nitric oxide bioavailability and adiponectin production in Chronic systolic heart failure: relation to severity of cardiac dysfunction.
- Diminished global arginine bioavailability as a metabolic defect in Chronic systolic heart failure.
- Measurement of the Neutron F_{2} Structure Function via Spectator Tagging with CLAS.
- Prognostic value of estimated functional capacity incremental to cardiac biomarkers in stable cardiac patients.
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.
Schools
Guangzhou Medical College
West Virginia University
Unc Hospitals At Chapel Hill
Conditions Treated
- Acute Leukemia
- Anemia
- Chronic Myeloid Leukemia (CML)
- Leukocytosis
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Education
-
University of North Carolina Hospitals -
West Virginia University -
Guangzhou Medical College
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629062450 |
| Last Name Of The Provider | TANG |
| First Name Of The Provider | WOZHAN |
| View All |
Similar Doctors
|
|
Dr. Michael A. Bergevin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jai C. Cha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Burton F. Alexander III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William W. Maclaughlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Celeste Ann T. Bremer, MD |
|
|
Dr. Kenneth F. More, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Valerio M. Genta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ludwig Sternlicht, MD |
|
|
Dr. Bhaskar G. Rao, MD |
|
|
Dr. Denise G. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria C. Uzquiano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolina B. Bacani-Longa, MD
This Doctor is OpenDoctor Recommended.
|